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Background: Obstetrician–gynecologists are important providers of primary health care to women, and the
hepatitisCvirus(HCV)infectionscreeningpracticesandrecommendationsprovidedbyobstetrician–gynecologists
for HCV-infected patients are unknown.
Methods: We surveyed American College of Obstetricians and Gynecologists (ACOG) Fellows, including 413
Fellows who were participating in the Collaborative Ambulatory Research Network (CARN) and 650 randomly
sampled Fellows, about HCV screening and counseling practices.
Results: In total, 74% of CARN members and 44% of non-CARN members responded. Demographics and
practice structure were similar between the two groups. More than 80% of providers routinely collected drug
use and blood transfusion histories from their patients. Of the respondents, 49% always screened for HCV
infectionwhen patientshad ahistoryof injection druguse,and35% screenedallpatientswho had receiveda blood
transfusion before 1992. For HCV-infected patients, 47% of the physicians always advised against breastfeeding,
70% recommended condom usewith a long-term steady partner, and 64% advised against alcohol consumption.
Respondents who considered themselves to be primary care providers were no more likely to screen or provide
appropriate counseling messages than were other providers.
Conclusions: Mostobstetrician–gynecologistsareroutinelycollectinginformation that canbeusedtoassessHCV
infection risk, butHCV screening practices and counseling that are provided for those with HCV infection are not
always consistent with current Centers for Disease Control and Prevention and ACOG recommendations.
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Obstetrician–gynecologists provide more office-
based general medical examinations for women
aged 15 years or older than either general family
practitioners or internists1, and may be the sole
primary care provider for some women. They can
provide an important service by assessing hepatitis
C virus (HCV) infection risk, testing women
with risk factors, and counseling HCV-positive
patients.
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ã 2003 The Parthenon Publishing Group 39The Centers for Disease Control and Preven-
tion (CDC) and the American College of
Obstetricians and Gynecologists (ACOG) have
both published recommendations for screening
individuals for HCV infection and counseling
those who are HCV infected. Current CDC
recommendations are that physicians in primary
care settings should provide HCV screening for
patients with risk factors for HCV infection, such
as illicit injection drug use or receipt of a trans-
fusion of blood or blood components before July
19922. ACOG has indicated that obstetrician–
gynecologists should include screening for HCV
infection among these risk factor groups as part of
primary and preventive care3. Neither ACOG
nor CDC has recommended that pregnant
women be routinely screened or that HCV-
infected women have Cesarean sections and
abstain from breastfeeding in order to avoid
transmission of the virus to the newborn2–4. CDC
does not recommend that HCV-infected patients
be counseled to change their sexual practices if
they have one long-term steady partner2. Both
CDC and the National Institutes of Health
recommend that HCV-infected patients should
be counseled to avoid alcohol2,5.
Theextent to whichobstetrician–gynecologists
have incorporated current HCV screening and
counseling recommendations into their practices
has not been determined. Aspart of a larger survey
on disease screening practices of a national sample
of obstetrician–gynecologists, we included
questions to determine how practitioners collect
information on HCV risk factors and to assess
their HCV screening and counseling practices.
METHODS
In February 2001, questionnaires were mailed
to two groups of Fellows of ACOG. The first
group, namely the Collaborative Ambulatory
Research Network (CARN), includes 413
ACOG Fellows who have volunteered to partici-
pate in surveys; CARN participants have been
chosen toreflect theage and genderdistributionof
all ACOG Fellows. Questionnaires were also sent
to a computer-generated random sample of 650
Fellows selected from the ACOG membership
list who had not previously been selected to
participate in an ACOG survey during the same
calendar year. Questions were in either multiple-
choice or scaled-response format. A second
mailing was sent 1 month after the first to those
individuals who did not respond to the first
mailing.
The survey included questions about the
practitioner, his/her practice, the demographic
characteristics of patients, and specific questions
about screening and counseling practices for HCV
infection. We performed univariate analyses to
evaluate factors associated with HCV risk factor
assessment, screeningandcounselingpractices,and
we performed stratified analyses to examine the
effect of practitioner age, location and practice
type, as well as practitioner self-description as a
primary care provider, on survey responses.
Survey responses were analyzed in SAS version 8
(SAS Institute, Cary, NC). We assessed differences
for categorical measures using the Chi-square test
statistic. A p-value of < 0.05 was considered to
be statistically significant.
RESULTS
Completed surveys were received from 307 (74%)
CARN members and 286 (44%) non-CARN
members. Respondents who had not seen
obstetric patients in the year 2000 (two CARN
respondents and eight non-CARN respondents)
were excluded. The characteristics of the CARN
and non-CARN groups are summarized in
Table 1. The median age of respondents was
48 years in the CARN group and 46 years in
the non-CARN group. In both groups, the
majority of respondents were male obstetrician–
gynecologists (rather than specialists in either
obstetrics or gynecology) who practiced in urban
or suburban settings. There were no statistically
significant differences between CARN and
non-CARN members in provider demographic
characteristics such as age, sex, race orethnicity,or
in practice characteristics such as location (urban,
rural or suburban), type (multispecialty group or
not) or proportionof patients receiving Medicaid.
However,CARN members weremorelikely than
non-CARN members to consider themselves to
be primary care providers (60 vs. 49%; p = 0.007).
Because of the demographic and practice
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respondents, we combined the CARN and
non-CARN responses for the analysis.
Most providers (89%) reported collecting
medical history information from new obstetric
and gynecological patients on standardized forms.
Among the providers who used a standardized
form,93%includedatleast onequestionthatcould
identify a risk factor for HCV infection (86%
requested information on use of injection drugs
and 87% resquested information on blood trans-
fusion). Respondents who considered themselves
to be primary care providers were no more likely
to collect information on drug use (p = 0.72) or
transfusion history (p = 0.43) on standardized
forms than were those who did not consider
themselves to be primary care providers. Provider
characteristics (including age, sex, practice type,
and practice location) were not associated with
collection of information on risk factors for
HCV infection.
HCV screening practices are summarized in
Table 2. Approximately half of the respondents
reported that they performed HCV infection
screening on all obstetric and gynecological
patients who reported ever having injected illicit
drugs, and 35% screened all individuals who
reported having received a transfusion before
1992. Physicians who considered themselves to be
primary care providers were not more likely to
screen patients with a history of illegal drug use
(p = 0.9) or transfusion (p = 0.9) compared with
physicians who did not identify themselves as
primary care providers (drug use, p = 0.9; trans-
fusion, p = 0.9). Furthermore, practice type
(multispecialty, solo practice or obstetrics/gyne-
cology group) was not associated with frequency
of screening for these two risk factors (drug use,
p = 0.31; transfusion, p = 0.15). Physicians whose
practices were located in urban or suburban areas
were more likely always to screen patients who
reported current or past illicit injection drug use
than were physicians whosepractices were in rural
settings (p = 0.037). Only 1.5% of respondents
reported routine screening for HCV infection of
all patients who received gynecology care in their
practice. However, 11% reported screening all
pregnant patients for HCV infection.
Table 3 summarizes the recommendations and
counseling measures for HCV-infected patients
reported by those physicians who were surveyed.
In total, 6% of providers reported that they always
recommended Cesarean sections for pregnant
women with HCV infection, and 47% always
advised against breastfeeding. A total of 70% of
the respondents advised HCV-positive women
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Characteristic
CARN group
(n = 305*)
Non-CARN group
(n = 278*)
Provider characteristics
Median age (years)
Male sex (%)
Self-identifies as a primary
care provider (%)
48
170 (56)
181 (60)
46
177 (64)
135 (49)†
Practice characteristics
Practice structure
Obstetrics/gynecology
group (%)
Solo practice
Other
Practice location
Urban (%)
Suburban (%)
Rural (%)
Patients receiving
Medicaid (%)
0–10%
11–40%
> 40%
141 (46)
75 (25)
87 (29)
42
41
17
38
41
21
118 (42)
64 (23)
96 (35)
44
41
15
37
39
24
*Totals vary for each characteristic due to missing responses;
†Pearson c
2 test: p < 0.001
Table 1 Demographic and practice characteristics of
survey respondents in the Collaborative Ambulatory
Research Network (CARN) and non-CARN groups
Provider recommends
screening (%)
Group screened Always Sometimes Never
Women who have ever
injected illegal drugs
Women who received a blood
transfusion before 1992
Pregnant women
49
35
11
40
46
56
11
19
33
Table 2 Groups screened and approximate frequency
of screening for hepatitis C virus infection as reported
by providersto use condoms with a steady partner, and avoid-
ance of alcohol was always recommended by 64%
of providers. Advice about breastfeeding, condom
use and alcohol consumption varied according to
age of the provider and location of the practice.
Younger providers were more likely to advise
HCV-infected women against breastfeeding
(p = 0.026) and alcohol consumption (p = 0.05)
and to recommend condom use with a steady
partner (p = 0.009). Providers in rural or suburban
areas were also more likely to advise HCV-
infected women against breastfeeding (p = 0.001)
and alcohol consumption (p = 0.05) and to
recommend condom use with a steady partner
(p = 0.001). Counseling messages did not differ
significantly among practitioners in different
types of practices.
DISCUSSION
Obstetrician–gynecologists have a key role in
providing primary care to women, and over half
of the ACOG members who responded to our
survey considered themselves to be primary care
providers. On the basis of our survey, some
obstetrician–gynecologists do not appear to be
consistently providing HCV screening for
their patients with the most common risk factors
for HCV infection in the USA. When HCV-
positive women are identified, some obstetrician–
gynecologists are providing counseling messages
that differ from the CDC and ACOG
recommendations.
Interpretations of these findings are subject to
several limitations. We were unable to compare
the demographic characteristics of survey respon-
dents with those of nonrespondents, and the
screening and counseling practices reported by
survey respondents were not confirmed by medi-
calrecordreviews. Inaddition,thesurveyquestion
format did not provide an opportunity for practi-
tioners to indicate that they always refer patients
with risk factors or HCV infection to another
physician, and therefore do not screen for or
counsel patients about HCV infection. However,
the survey findings are consistent with surveys
of other physician specialties. In one recently
published national survey of internists and family
physicians, 70% of respondents reported that they
always perform HCV screening for patients with
risk factors6. Finally, due to survey length limita-
tions, we did not determine whether the differ-
ences between survey respondents’ practices and
CDC or ACOG recommendations were due to
lack of knowledge or to disagreement with the
recommendations. A follow-up survey may be
necessary to identifythereasonswhyHCV-related
practice guidelines are not followed by some
obstetrician–gynecologists.
HCV infection is the most common chronic
bloodborne infection in the USA, with an esti-
mated 2.7 million individuals infected, including
approximately 900 000 women7. The identifica-
tion of HCV-infected women is important to
enable appropriate medical referral, treatment and
risk-reduction counseling to be offered. Current
Screening and counseling for hepatitis C infection Boaz et al.
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Recommendations given to
all HCV-infected patients
Age quartile (%)
Total (%) < 40 40–47 48–54 ‡ 55
Cesarean section 6 6 8 5 4
Avoid
breastfeeding*
Use condoms
with steady partner*
Avoid
alcohol†
47
70
64
55
78
67
50
71
68
37
65
60
43
63
56
*c
2 test for trend by age of provider: p < 0.05; †c
2 test for trend by age of provider: p = 0.053
Table 3 Percentage of providers who made specific recommendations to patients with hepatitis C virus infection,
according to provider age groupScreening and counseling for hepatitis C infection Boaz et al.
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and past use of injected illegal drugs and receipt
of a blood transfusion or blood products before
July 1992 are among the most important risk
factors for HCV infection in the USA. An esti-
mated 60% ofnewHCV infectionsareattributable
to injection of illegal drugs, and an estimated
79% of current injection drug users have HCV
infection2. More than 80% of the survey respon-
dents collected patient information on injection of
illegal drugs and transfusion history that could be
used to assess the HCV infection risk, butless than
half reported routine testing of all patients with
these risk factors. Some practitioners tested all
pregnant women (a low-risk group in most
settings), while many others did not test women
with risk factors. These results indicate that
obstetrician–gynecologists may benefit from
education about the rationale for the recom-
mended strategies for HCV infection screening.
The risk of HCV transmission from mother
to infant during the pre- and perinatal period is
estimated to be approximately 4–6%2,8–10. The
only factors that have consistently been shown to
increase the risk oftransmission are thepresence of
HCV RNA in maternal blood at the time of
birth and HCV/HIV coinfection2,11,12. Most
studiesthathaveassessed whethermodeofdelivery
influences the risk of HCV transmission to a new-
born born to an HCV-positive, HIV-negative
woman have foundthat mode of delivery is not an
importantrisk factorforperinataltransmission11–14.
A randomized controlled trial to evaluate the
impact of mode of delivery on the risk of peri-
natal transmission has not been performed. Few
of the surveyed physicians in our study reported
that they screened all pregnant women or recom-
mended Cesarean sections for all HCV-infected
women.
HCV can be found in breast milk15, but no
instance of transmission via breast milk has been
documented. Most studies, including a recent
meta-analysis, have not found breastfeeding to be
a risk factor for perinatal transmission10–13,15,16.
CDC recommends that HCV-infected women
with cracked or bleeding nipples should consider
abstaining from breastfeeding, but there is no
general contraindication to breastfeeding2. In
addition, a recent ACOG committee opinion
stated thatcurrentevidenceindicatesbreastfeeding
does not appreciably increase the risk of
transmission ofHCV4.However,almosthalfofthe
survey respondents always advised HCV-infected
mothers to avoid breastfeeding their infants.
The majority of the survey respondentsrecom-
mended that HCV-infected women should use
condoms with their steady partners. Sexual trans-
mission of HCV infection from one long-term,
steady sexual partner to the other sometimes
occurs, but at low frequency. In most studies, the
prevalence of HCV infection is low among
long-term partners of HCV-infected individuals,
unless the partner has other risk factors for HCV
infection2,17–19. Rather than advising routine
condom use, the available data indicate that health
care providers should discuss this low level of
risk with HCV-infected patients, noting that
current recommendations do not advise patients
to change their sexual practices if they are in a
long-term steady sexual relationship2.
On the other hand, 36% of the respondents did
not always counsel their HCV-positive patients
about limiting alcohol intake. Alcohol con-
sumption contributes to the progression of liver
disease, andcliniciansshouldadvise HCV-infected
patients to reduce alcohol intake as part of the
medical management of HCV infection5.
For diseases associated with routine gyneco-
logical care, obstetrician–gynecologists deliver
preventive medicalservices effectively1. However,
in their role as primary care providers for women,
obstetrician–gynecologists may also need to pro-
vide screening and counseling services for non-
gynecologic medical conditions such as HCV
infection. In addition to the various HCV-related
ACOG technical bulletins that have already been
published, alternative educational strategies are
necessary to integrate prevention counseling
into obstetrician–gynecologists’ general practices
effectively.
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